4
Indian Journal of Experimental Biology Vol. 40, March 2002, pp. 273-276 Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucurna pruriens and Tinospora cordifolia) extracts J K Grover* , S S Rathi & V Vats Departments of Pharmacology, All India In stitute of Medical Sciences, Ansari Nagar, New Delhi 110029, India Received 11 June 2001; revised 19 December 2001 Extract of M. charanlia (200mg/kg), £. jambolana (200mg/kg), M. pruriens (200mg/kg) and T. co rdi/ alia (400 mg/kg) was administered for 50 days in STZ induced diabetic mice, the plasma glucose concentration was reduced by 24.4, 20.84, 7.45 a nd 9.07 % respectively. Tail nick latency (TFL) and gastric transit percentage were significantly higher in diabetic controls versus normal controls. M. charanlia and £. jambo/ana modified it favorably while M. pruriens and T. co rdi/ alia did not exert any favorable change. Diabetic neuropathy is the complication of diabetes mellitus and occurs in almost 50% of diabetic patients I. Patients with autonomic neuropathy are characterized by maladaptation to everyday stress situations like exercise and hypoglycemia which predispose them to a higher risk of death 2 . Gastrointestinal symptoms are also responsible for substantial morbidit/ A and approximately 30 to 50 % of patients with long-standing diabetes mellitus have delayed gastric emptying time and up to 60% have seve re intestinal symptoms like nausea, vomiting, diarrhoea and constipation 3 . Presently, other than symptomatic control no effecti ve treatment is available though metabolic control has been shown to strongly influence the development of diabetic neuropathy and gastroparesis 4 . In the recent years, popularity of complementary medicine has increased as shown by surveys conducted in Australia and US, which indicate that almost 48.5 and 34 % respondents had used at least one form of unconventional therapy including herbal medicine s . 6 . Dietary measures and traditional plant therapies prescribed by Ayurveda and other indigenous systems of medicine have been used commonly in India 7 . In the present study, 4 plants namely Momordica charantia ; Eugenia jambolana ; Mucuna pruriens; and Tinospora cordifolia with previously confirmed anti-hyperglycemic activity were selected for the present study. *Correspondent author- Fax: 91-11-6862663; Email: jkgrover @hotmail.com Anti-hyperglycemic activity of M. charantia 8 , E. jambolana 9 , M. pruriens lo and T. cordifolia" has been reported earlier but none of these studies have revealed the effect of plant extracts on development of diabetic complications such as neuropathy and h I . 1213 M h . gastropat y. n our prevIOus stu les . , . c arantta and E. jambolana have shown higher anti- hyperglycemic effect as compared to T. cordifolia and M. pruriens in mild (plasma sugar> 180 mg/dl , duration 21 days), moderate (plasma sugar> 280 mg/dl, duration 120 days) and severe (plasma sugar> 400 mg/dl, duration 60 days) diabetic rat s. In addition, M. charantia and E. jambolana also partially restored altered hepatic and skeletal muscle glycogen content and hepatic glucokinase, hexokinase, glucose- 6-phosphate and phosphofructokinase levels. E. jambolana and M. charantia also attenuated certain parameters in STZ induced diabetic nephropathyl 4 and dietary fructose 'induced in sulin resistance in normal rats IS . Materials and Methods Extract of plant parts-Fresh green fruit of Momordica charantia and dried kernels of ripen Eugenia jambolana were collected locally. Cuticle of M. charantia fruit was peeled off and macerated in an electric mixer (Electro Com, New Delhi), the kernels of E. jambolana were grounded in an electric grinder. The macerated pulp of M. charantia and the E. jambolana powder were then soaked separately in equal amount of water and stirred intermittently and then left overnight. This pulp was then filtered

Amelioration of experimental diabetic neuropathy and …nopr.niscair.res.in/bitstream/123456789/17246/1/IJEB 40(3) 273-276.pdf · Amelioration of experimental diabetic neuropathy

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Amelioration of experimental diabetic neuropathy and …nopr.niscair.res.in/bitstream/123456789/17246/1/IJEB 40(3) 273-276.pdf · Amelioration of experimental diabetic neuropathy

Indian Journal of Experimental Biology Vol. 40, March 2002, pp. 273-276

Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucurna pruriens

and Tinospora cordifolia) extracts

J K Grover*, S S Rathi & V Vats

Departments of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India

Received 11 June 2001; revised 19 December 2001

Extract of M. charanlia (200mg/kg), £. jambolana (200mg/kg), M. pruriens (200mg/kg) and T. cordi/alia (400 mg/kg) was administered for 50 days in STZ induced diabetic mice, the plasma glucose concentration was reduced by 24.4, 20.84, 7.45 and 9.07 % respectively. Tail nick latency (TFL) and gastric transit percentage were significantly higher in diabetic controls versus normal controls. M. charanlia and £. jambo/ana modified it favorably while M. pruriens and T. cordi/alia did not exert any favorable change.

Diabetic neuropathy is the complication of diabetes mellitus and occurs in almost 50% of diabetic patients I . Patients with autonomic neuropathy are characterized by maladaptation to everyday stress situations like exercise and hypoglycemia which predispose them to a higher risk of death2.

Gastrointestinal symptoms are also responsible for substantial morbidit/A and approximately 30 to 50 % of patients with long-standing diabetes mellitus have delayed gastric emptying time and up to 60% have severe intestinal symptoms like nausea, vomiting, diarrhoea and constipation3. Presently, other than symptomatic control no effecti ve treatment is available though metabolic control has been shown to strongly influence the development of diabetic neuropathy and gastroparesis4 . In the recent years, popularity of complementary medicine has increased as shown by surveys conducted in Australia and US, which indicate that almost 48.5 and 34 % respondents had used at least one form of unconventional therapy including herbal medicines.6. Dietary measures and traditional plant therapies prescribed by Ayurveda and other indigenous systems of medicine have been used commonly in India7. In the present study, 4 plants namely Momordica charantia ; Eugenia jambolana ; Mucuna pruriens; and Tinospora cordifolia with previously confirmed anti-hyperglycemic activity were selected for the present study.

*Correspondent author- Fax: 91-11-6862663; Email: [email protected]

Anti-hyperglycemic activity of M. charantia8, E. jambolana9, M. pruriens lo and T. cordifolia" has been reported earlier but none of these studies have revealed the effect of plant extracts on development of diabetic complications such as neuropathy and

h I . d· 1213 M h . gastropat y. n our prevIOus stu les . , . c arantta and E. jambolana have shown higher anti­hyperglycemic effect as compared to T. cordifolia and M. pruriens in mild (plasma sugar> 180 mg/dl , duration 21 days), moderate (plasma sugar> 280 mg/dl, duration 120 days) and severe (plasma sugar> 400 mg/dl, duration 60 days) diabetic rats. In addition, M. charantia and E. jambolana also partially restored altered hepatic and skeletal muscle glycogen content and hepatic glucokinase, hexokinase, glucose-6-phosphate and phosphofructokinase levels. Moreo~er, E. jambolana and M. charantia also attenuated certain parameters in STZ induced diabetic nephropathyl4 and dietary fructose 'induced insulin resistance in normal rats IS .

Materials and Methods Extract of plant parts-Fresh green fruit of

Momordica charantia and dried kernels of ripen Eugenia jambolana were collected locally . Cuticle of M. charantia fruit was peeled off and macerated in an electric mixer (Electro Com, New Delhi), the kernels of E. jambolana were grounded in an electric grinder. The macerated pulp of M. charantia and the E. jambolana powder were then soaked separately in equal amount of water and stirred intermittently and then left overnight. This pulp was then filtered

Page 2: Amelioration of experimental diabetic neuropathy and …nopr.niscair.res.in/bitstream/123456789/17246/1/IJEB 40(3) 273-276.pdf · Amelioration of experimental diabetic neuropathy

274 INDIAN J EXP SIOL, MARCH 2002

through a coarse sieve and the filtrate was dried at reduced temperature. Respective yield of M. charantia and E. jambolana was 80.4 gmlkg of fruit and 73 gmlkg of kernel. To increase the shelf life and uniformity, the extracts were completely lyophilized by continuous freeze drying operation of 54 hr (Christ freeze dryer, alpha 1-4, Germany), yielding 64 and 51 g/ lOOg of M. charantia and E. jambolana extract respectively.

Alcoholic and aqueous ex tracts of T. cordiJolia and M. pruriens were received as gift from Brawn Pharmaceuticals LTD, Faridabad (India). All the extracts were suspended in 1 % carboxy methylcellulose (Central Drug House, New Delhi) and given orally.

Sample collection-Blood was collected retro­orbitally from the inner canthus of the eye under light ether anesthesia using capillary tubes (Micro Hematocrit Capillaries, Mucaps). Blood was collected in fresh vials containing sodium fluoride and sodium oxalate as anti-coagulantlanti-glycolytic agents and plasma was separated in a T8 electric centrifuger (Remi Udyog, New Delhi) at 2000 rpm for 2 min.

Preparation of diabetic animals-Male albino mice (20-35g) were fasted for overnight and given a bolus injection of STZ (150 mg/kg ; ip) dissolved in citrate buffer (3mM ; pH 4.5). After 10 days, serum glucose was estimated using commercially available Autopak® kit , Bayer Diagnostics, Baroda. Mice exhibiting plasma glucose levels > 300 mg/dl were used for further study.

Experimental design-Albino mice (30-50g) of both sexes (8-10 weeks old) were obtained from the Institute and maintained on standard chow diet during the experiment. The animals were randomized in the following groups with a acclimatization period of 2-3 days before initiation of experiment. Mice were divided into 6 groups having 8 mice in each group. In group I, mice received saline daily and served as normal control. In group II to VI, mice received a single intra peritoneal injection of 150 mg/kg STZ. In group II, mice received saline daily and served as a diabetic control. Group III received 200 mg of lyophilized powder of M. charantia, group IV received 200 mg of lyophilized powder of E. jambolana, and group V received 400 mg of aqueous extract of T. cordiJolia and group VI received 200 mg/day of alcoholic extract of M. pruriens. The doses of the plant extracts were decided on the basis of a previous stud/ 2,13. All the extracts were given

PO every day till the end of experiment (up to day 50). Animals described as fasting had been deprived of food for at least 16 hr but given water ad libitum.

Plasma glucose-Glucose levels were estimated by commercially available glucose kits based on glucose oxidase method 16 on every 10 day for 50 days (Autopak®, Bayer Diagnostics, Baroda).

Tail flick latency (TFL)-On day 50 of the experiment, TFL was studied as a parameter to assess diabetic neuropathy on electrical analgesiometer (Techno, India), before and after morphine injection (5mg/kg; sc) at 30 and 60 min intervals l7 . Maximum latency period for the mice to flick its tail was fixed at 15 sec lest the mouse burnt its tail. Index of analgesia (%) in mice was calculated by the following formula: Index of analgesia (%) = Test Latency x 100! Basal Latency

Rate of transit of charcoal in CIT-It was determined on day 50 of the experiment by forced feeding of charcoal (12.5%) and gum acacia (12.5 %) 18. Ten min after feeding charcoal, animals were sacrificed and intestine was removed. Total length of intestine and distance travelled by charcoal in the intestine were measured and GTT was calculated as distance travelled by charcoal in the intestine divided by total length of intestine.

Statistical analysis-The results were analyzed for statistical significance by Student's t test using computerised software, GraphPAD, InStat, 1990, Version 1.14, INSERM 920666S , India.

Results and Discussion Aim of the present work was to study the effect of

50 days of persistent hyperglycemia on TFL (neuropathy) and rate of transit of charcoal in GIT (gastropathy) and whether 4 plant extracts (M. charant ia ; E. jambolana; M. pruriens and T. cordiJolia ) modify the outcome favorably. In addition, modification of analgesic effect of morphine and glucose levels were also assessed in the same. Effect of administration of plant extracts of M. charantia, E. jambolana, M. pruriens and T. cordiJolia for 50 days in STZ diabetic mice is given in Table 1 . Total reduction of blood glucose was of 24.4, 20.84, 9.07 and 7.45 % respectively.

Effect of administration of plant extracts on rate of transit of charcoal in GIT in STZ diabetic mice has been shown in Table 2. There was a significant difference in mean rate of transit in diabetic control vs normal control (83.00±6.38 vs 99.16± 1.32%

Page 3: Amelioration of experimental diabetic neuropathy and …nopr.niscair.res.in/bitstream/123456789/17246/1/IJEB 40(3) 273-276.pdf · Amelioration of experimental diabetic neuropathy

GROVER et al.: AMELIORATION OF DIABETIC NEUROPATHY AND GASTROPATHY 275

Table 1-Effect of plant extracts on glucose (mg/%) leve ls in streptozotoc in (l50/mg/kg) diabetic mice

[Values are mean±SD for 8 animals in each group]

Group o day Day 10 Day 20 Day 30 Day 40 Day 50 Day 60

NC 96.3 ±3.9 94.98 ±4.67 95.5 ±4.85 95 .5±4.85 100.0 1 ±6.28 94.26± 4.38 92 .03 ±4.32

DC 90.3 ± 2. 1 437.05 ± 12.8** 44 1.1 ± 19.9** 471.3± 19.3** 470.5 ± 12.3** 450.5 ± 10.03** 439.5 ± 14.2**

MC 98.61 ±5.33 450.8 1 ± 13 .39 449.33 ± 22.33 418±22.08 398. 16± 12.44** 366± 14.61** 339.66± 14.22*** (24.4)

EJ 95.9±3.4 439.8±7.9 456.5 ±22.9 466.6± 15.4 430.6± 18.8* 399.3 ± 29.4** 361.8 ± 3 1.1 *** (20.84)

MP 95.21 ±2.97 437.61 ±9.8 1 464.66 ± 15.57 472±12.5 473 .83± 20.9 447±1 8.4 430± 14.97** (7.45)

TC 99.06±2.6 454.7 ± 11 .3 462.8± 14.4 482 .3± 8.5 462 .8 ±6.8 455.8± 12.9 420.8 ± 13.3* (9.07)

., Diabetic control was compared with the normal, and experimental groups were compared with their own corresponding values on day 10. NC- Non-di abetic control; DC-diabetic control; MC-M. charantia; EJ -E. jambolana; MP-M. pruriens; TC - T. cordifolia. Significant at *P<O.O I, **<0.001, ***<0.0001

Table 2-Effect of STZ and plant extracts on gastrointest inal transit time in mice

[Values are mean ± SD fo r 8 an imals in each group]

Groups

Normal

Di abetic Control

M. charantia

£. jambolana

M. pruriens

T. cordifolia

Rate of transit of charcoal in GIT (%)

99. 16±1.32

83.00±6.38**

90.28±5.4 1*

90.20±5.20*

80.60±5.24

83.60±5.20

Diabetic cont ro l was compared with the normal, and experimental groups were compared with diabetic cont ro l

Significant at * P < 0.05 ; and **< 0.005

respectively) . This finding is consistent with the previous finding 19 that gastric emptying rate is faster in hypoglycemic state and slower in case of hyperglycemic state. Hyperglycemia20 has been implicated as the main factor responsible for delay in gastric emptying though direct effects of metabolic derangement via an altered autonomic function (i .e. neuropathy) cannot be ruled oue. M. charantia and E: jambolana caused a significant increase in gastric transit percentage with comparison to diabetic controls (90.28±5.41 and 90.20±5.20 versus 83.00±6.38 respectively) . M. pruriens and T. cordifolia had no such effect. Although M. charantia and E. jambolana caused a significant decrease in serum sugar levels (24 and 21 % reduction respectively), an euglycemic state was not achieved.

Table 3 - Effects of pl ant extrac ts on TFL in mice (in sec)

[Values are mean ± SD for 8 animals in each group]

Groups o min 30 min 60 min

Control 6. 11 ± 1.09 9.01 ± 1.8 12.05 ± 0.7

Diabetic contro l 10.6 1 ± 0.9* 11.8 ± 1.6 12.7 ± 1.4

M. charantia 7.95 ± 0.9 10.52 ± 1.2 13.4 1 ± 1.5

£. jambolana 8.5 ± 1.3 9.85 ± 1.7 12.55 ± 1.3

M. pruriens 8.92 ± 0.5 9.71 ± 1.2 12.0 ± 0.9

T. cordifolia 8.5 ± 1.3 11.55 ± 1.7 13.56 ± 1.3

Diabetic control was compared with normal and experimental groups were compared with diabetic control Significant at * P < 0.05

Thus, it is likely that M. charantia and E. jambolana normalised rate of transit of charcoal in GIT through an unknown independent mechanism other than its anti-hyperglycemic effect.

Effect of administration of plant extracts on TFL of STZ diabetic mice is shown in Table 3 and index of analgesia has been shown in Table 4 . TFL was significantly higher in diabetic mice (l 0.61 ± 2.98) as compared to normal control (6.11 ± 1.09) before administration of morphine. These results are in agreement with the previous findings21-23 . However, decrease in hot plate latenc/4 as well as no change has also been described earlier25.26 . In the present study, TFL in treated groups before the administration of morphine was insignificantly lesser than di abetic controls. Daily administration of M. charantia and E. jambolana insignificantly prevented the rise in basal

Page 4: Amelioration of experimental diabetic neuropathy and …nopr.niscair.res.in/bitstream/123456789/17246/1/IJEB 40(3) 273-276.pdf · Amelioration of experimental diabetic neuropathy

276 INDIAN J EXP BIOL. MARCH 2002

Table 4- Effects of plant extracts on index of analgesia in mice (i n %)

[Values are mean ± SD for 8 animals in each group]

Group 30 min 60 min

Control 147 .6 197.2 1 Diabetic control 111.2 1 11 9.69 M. charantia 132.32 168.67 E. jambo/ana 115 .88 147 .64 M. pruriens 108.85 134.52 T. cordifolia 135.88 159.52

TFL in comparison to diabetic controls (Table 3). Insulin has been shown to reverse the blunting of anti­nocicepti ve effect of morphine seen in diabetic animals21 possibly by decreas ing opioid receptor affinity or change in the configuration caused by hyperglycemi a27 . Though the plant extracts (particularly M. charantia and E. jambolana) caused a significant reduction in glucose level s, it was not enough to normali ze the ri se seen in basal TFL in treated groups .

References I Dyck P J, Kranes J L, O'Brain P C, Kitchy W J, Low P A &

Melton I J, The prevalence by stagged severity at va ri ous types of diabetic neuropathy in a population based cohort : The Rochester neuropathy study , Neurology, 43 (1993) 8 17.

2 Ewing D J, Campell J W & Clark B B, Mortality in diabetic au tonomi c neuropathy , Lancet, I ( 1976) 60 1.

3 Camilleri M, Gastrointestinal problems 111 diabetes, Endoerinol Metab C/in N Am, 25 (1996) 361.

4 Diabetes Control and Complication (DCCT) Research Group, Effect of intensive therapy on the development and progression of diabetic neuropathy in the di abetes control and compli cat ion trial, Kidney Int, 47 (1995) 1703.

5 Eisenberg D M, Kessler R C, Foster C, Norlock FE, Calkins D R & Delbanco T L, Unconventi onal medicine in the Un ited States. Prevalence, costs, and patterns of use, N Eng J Med, 328 (1993) 246.

6 Maclennan A H, Wil son D H & Taylor A W, Prevalence and cost of al ternati ve medi cine in Australia, Lancet, 347 (1996) 569.

7 Grover J K & Vats Y, Shifting Paradigm "From Convent ional to Alternate Med ici ne." An introduction on Traditional Indian Med icine, Asia Pacific Biotech News , S (200 1) 28.

8 Kedar P & Chakrabarti C H, Effects of bittergourd (Momo rdica charantia) seed and glibenclamide in streptozotocin induced diabetes mellitus, Indian J Exp Bioi, 20 (1982) 232.

9 Bansal R, Ahmad N & Kidwai J R, Effects of oral administrati on of Eugenia j ambo/ana seeds and chloropropamide on blood glucose level and pancreatic cathepsin B in rat, Indian J Biochelll Biop/zys, 18 (198 1) 377.

10 Dhawan B N, Dubey M P, Mehrotra B N, Rastogi R P & Tandon J S. Screening of Indian pl ants for biological ac ti vity. Part IX, Indian J Exp Bioi, 18 (1980) 594.

II Wadood N, Wadood A & Shah S A, Effect of Tinospora cordifolia on blood glucose and total lipid levels of normal and alloxan diabetic rabbits, Plal1la Med 58 (199 1) 131 .

12 Grover J K, Vats V & Rathi S S, Anti-hyperglycemic cffects of Eugenia jambolana and Tinospora cordifolia in ex perimental diabetes and their effects on key metabolic enzy mes involved in carbohydrate metabolism, J Ethnopharmaco/, 73 (2000) 461.

13 Rathi S S, Grover J K & Vats V, Anti-hyperglycemic effects of Momordica charantia and Mucul/a pruriens in experimental diabetes and their effect on key metabol ic enzy mes involved in carbohydrate metabolism. Phytother Res, 200 I (in press).

14 Grover J K, Vats Y, Rathi S S & Dawar R. Traditional Indian anti-diabetic plants attenuate renal hypertrophy, urine volume & albuminuria in streptozotoc in ind uced diabetic mice. J Ethnophannacol, 76 (200 1) 233.

IS Vats Y, Grover J K, Tandon N, Gupta N & Rathi S S, Treatment with extracts of Momordica charal1lia prevents hyperglycemia and Eugenia jamholal1a prevents hyperglycemia and hyperinsulinemia in fructose fed rats, J Et/znopharmaco/, 76 (200 1) 139.

16 Trinder P, Determinati on of blood glucose using an ox idase­peroxidase system with a non-carcinogenic chromogen, J Clin Pathot, 22 ( 1969) 158.

17 Grover J K & Rathi S S, Anti-inflammatory ac ti vity of Benincasa hispida, Indian J Pharmacol, 13 (1994) 26.

18 Grover J K, Rathi S S & Vats Y, Preliminary study of fresh juice of Benincasa hispida on morphinc addiction in mice, Fitoterapia, 71 (2000) 707.

19 Chu PC, Lin M T, Schia L R & Leu S Y, Alterations in physiologic functi ons and brain monoamine content in streptozotocin di abetic rats, Diabetes, 35 (1986) 481 .

20 Levin A S, Morley J E, Wi lcox G & Brown D M, Tail pinch behavior and analgesia in diabetic mice, Physio Behav , 28 (1982) 39.

21 Mahajan A, Chakrabarty K, Mishra T K & Chakrabarty A S, Nociception, Antinociceptive potency of morphine in streptozotocin induced diabeti c rats, Indian J Physiol Pharmacol, 41 ( 1997) 416.

22 Raz I, Hasadai D, Seltzer Z & Melmed R N, Effect of hyperglycemi a on pain percept ion and on efficacy of morphine analgesia in rats, Diabetes, 37 (1 988) 1253.

23 Brase D A, Han T H & Dewey W L, Effect of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain, Diabetes, 36 ( 1987) 11 73.

24 Forman L J, Est ilow S, Lewis M & Yasilenko P Streptozotoein diabetes immunoreacti vc J3-endorphin leve l ~ and pain perception after 8 wk in fema le rats, Diabetes, 35 ( 1986) 1309.

25 Horowitz M, Maddox A, Harding P E, Chatteron B E, Wishart J & Shearman D J C, The effect of cisapride on gastric and esophageal emptying in Insu lin dependent diabetes mellitus. Gastoenterology, 92 (1987) 1899.

26 Morley G K, Mooradian A D, Lev ine A S & Morley J E, Mechani sm of pain in di abeti c peripheral neuropathy- Effect of glucose on pain perception in humans, Am J Med, 77 (1984), 79.

27 Chang E B, Frdork R N & Field M, Experimental di abetic diarrhoea in rats. Intestinal mucosal denerva ti on, hyposensti vity and treatment with clonid ine, Gastroenterology, 91 (1986) 564.